Cargando…

The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke

BACKGROUND: Alteplase is the only approved thrombolytic agent for acute ischaemic stroke. The overall benefit from alteplase is substantial, but some evidence indicates that alteplase also has negative effects on the ischaemic brain. Tenecteplase may be more effective and less harmfull than alteplas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Logallo, Nicola, Kvistad, Christopher E, Nacu, Aliona, Naess, Halvor, Waje-Andreassen, Ulrike, Asmuss, Jörg, Aamodt, Anne Hege, Lund, Christian, Kurz, Martin W, Rønning, Ole Morten, Salvesen, Rolf, Idicula, Titto T, Thomassen, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029902/ https://www.ncbi.nlm.nih.gov/pubmed/24886064 http://dx.doi.org/10.1186/1471-2377-14-106

Ejemplares similares

Characteristics and predictors of stroke mimics in young patients in the norwegian tenecteplase stroke trial (NOR-TEST)
por: Jacobsen, Eskil, et al.
Publicado: (2023)

A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS)
por: Nacu, Aliona, et al.
Publicado: (2015)

NOR-SASS (Norwegian Sonothrombolysis in Acute Stroke Study): Randomized Controlled Contrast-Enhanced Sonothrombolysis in an Unselected Acute Ischemic Stroke Population
por: Nacu, Aliona, et al.
Publicado: (2017)

Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022)

Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke
por: Nguyen, Chi Phuong, et al.
Publicado: (2023)

Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
por: Yang, Nan, et al.
Publicado: (2023)

Replacing Alteplase with Tenecteplase: Is the Time Ripe?
por: Singh, Nishita, et al.
Publicado: (2023)

Tenecteplase vs. alteplase for acute ischemic stroke: a systematic review
por: Potla, Neha, et al.
Publicado: (2022)

Is Tenecteplase a Viable Alternative to Alteplase in the Treatment of Acute Ischemic Stroke?
por: Vaishnav, Anand Girish
Publicado: (2022)

Switching to Tenecteplase from Alteplase for Ischemic Stroke: Is it the Time for Universal Adoption?
por: Kharel, Sanjeev, et al.
Publicado: (2022)

Is higher body temperature beneficial in ischemic stroke patients with normal admission CT angiography of the cerebral arteries?
por: Kvistad, Christopher Elnan, et al.
Publicado: (2014)

Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?
por: Mahmood, Ammad, et al.
Publicado: (2022)

Admission C – reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The 'Bergen stroke study'
por: Idicula, Titto T, et al.
Publicado: (2009)

Is tenecteplase ready to replace alteplase to treat acute ischaemic stroke? The knowns and unknowns
por: Dong, Yi, et al.
Publicado: (2021)

Biosimilar Tenecteplase Versus Alteplase in Acute Ischemic Stroke: A Real World Study
por: Mohan, Ayush, et al.
Publicado: (2023)

Tenecteplase vs. alteplase for treatment of acute ischemic stroke: A systematic review and meta-analysis of randomized trials
por: Kobeissi, Hassan, et al.
Publicado: (2023)

U‐curve relation between cholesterol and prior ischemic stroke
por: Bringeland, Gerd Haga, et al.
Publicado: (2016)

A Comparative Study of Hemorrhagic Conversion Patterns After Stroke Thrombolysis With Alteplase Versus Tenecteplase
por: Ezzeldin, Mohamad, et al.
Publicado: (2023)

Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study
por: Logallo, Nicola, et al.
Publicado: (2011)

Tenecteplase Thrombolysis in Posterior Circulation Stroke
por: Alemseged, Fana, et al.
Publicado: (2021)

Tenecteplase in Ischemic Stroke: Challenge and Opportunity
por: Li, Guangshuo, et al.
Publicado: (2022)

Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials
por: Xu, Na, et al.
Publicado: (2018)

A Family History of Stroke Is Associated with Increased Intima-Media Thickness in Young Ischemic Stroke - The Norwegian Stroke in the Young Study (NOR-SYS)
por: Øygarden, Halvor, et al.
Publicado: (2016)

Tenecteplase and Alteplase for Thrombolysis of Acute Ischemic Stroke within 4.5 Hours: An Efficacy and Safety Study
por: Dhar, Nikita, et al.
Publicado: (2022)

A stress-related explanation to the increased blood pressure and its course following ischemic stroke
por: Kvistad, Christopher Elnan, et al.
Publicado: (2016)

Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit—TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unit
por: Bivard, Andrew, et al.
Publicado: (2022)

Clinical presentation and diffusion weighted MRI of acute cerebral infarction. The Bergen Stroke Study
por: Naess, Halvor, et al.
Publicado: (2009)

Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Shen, Ziyi, et al.
Publicado: (2023)

Recanalization before Thrombectomy in Tenecteplase vs. Alteplase-Treated Drip-and-Ship Patients
por: Seners, Pierre, et al.
Publicado: (2019)

Early Experience With Tenecteplase at a Comprehensive Stroke Center
por: Panezai, Spozhmy, et al.
Publicado: (2021)

Tenecteplase versus Alteplase for the Management of Acute Ischemic Stroke in a Low-income Country–Nepal: Cost, Efficacy, and Safety
por: Nepal, Gaurav, et al.
Publicado: (2018)

Real-world comparative safety and efficacy of tenecteplase versus alteplase in acute ischemic stroke patients with large vessel occlusion
por: Psychogios, Klearchos, et al.
Publicado: (2021)

Tenecteplase in wake-up ischemic stroke trial: Protocol for a randomized-controlled trial
por: Roaldsen, Melinda B, et al.
Publicado: (2021)

The efficacy and safety of tenecteplase versus alteplase for acute ischemic stroke: an updated systematic review, pairwise, and network meta-analysis of randomized controlled trials
por: Abuelazm, Mohamed, et al.
Publicado: (2022)

Trail Toward Tenecteplase
por: Srivastava, Trilochan, et al.
Publicado: (2022)

Tenecteplase or Alteplase Better in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion: A Single Center Observational Study
por: Teivane, Agnete, et al.
Publicado: (2022)

Stroke patients’ knowledge about cardiovascular family history - the Norwegian Stroke in the Young Study (NOR-SYS)
por: Øygarden, Halvor, et al.
Publicado: (2015)

Using Tenecteplase for Acute Ischemic Stroke: What Is the Hold Up?
por: Zitek, Tony, et al.
Publicado: (2020)

Does a History of Migraine Affect the Rate of Thrombolysis in Young Stroke Patients?
por: Øygarden, Halvor, et al.
Publicado: (2013)

Microemboli-monitoring during the acute phase of ischemic stroke: Is it worth the time?
por: Idicula, Titto T, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jlgjdcok6v95lgeek08tvrqk34